By Nicola Miller, RARE Revolution Magazine
Interview with Giacomo Chiesi, executive vice president ofGlobal Rare Diseases, Chiesi Group

“The most important thing, for us, is orientation to patients and the willingness to make decisions which ultimately benefit patients, even if sometimes they’ll come at a short-term sacrifice and cost for the company. And that’s something that we absolutely have in common and share with the Arbor team.” Giacomo Chiesi

---